Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

N/ANot Yet RecruitingNCT06691451

Asmaa mohammed abdelaal abdelaal93 enrolled

Overview

Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission

Inflammatory bowel diseases (IBD) are systemic conditions characterized by multiple intestinal and extra-intestinal manifestations related to the associated chronic inflammatory state. Among their diverse extra-intestinal complications, venous thromboembolism (VTE) remains one of the most under recognized causes of morbidity and mortality in these patients, highlighting the need for a better understanding of the underlying mechanism of hypercoagulability, in addition to the role of acquired and inherited risk factors that further increase the risk of thrombosis with its impact on patients' outcomes.\[1, 2\]

Study Type

OBSERVATIONAL

Enrollment

Conditions

Inflammatory Bowel Diseases

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age (18yrs - 65yrs) both sex Exclusion Criteria: * Presence of acquired cause (pregnancy, recent surgery, history of drug, History of malignant Disease, History of blood or blood product transfusion in last 4 weeks)

Outcomes

Primary Outcomes

Comparison between the number of IBD patients with tendency to thrombosis in cases of activity-

-investigate the presence of multiple mutations associated with IBD patients with or without vascular complications.

Time frame: Baseline

Central Contacts

Asmaa Mohammed Abdelaal, Master

CONTACT

01066239562 Asmaamohammedabdelaal0098@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.